Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Dackis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|December 20, 2003
Glutamatergic agents for cocaine dependenceCharles Dackis, Charles O'Brien
Nature Neuroscience|October 28, 2005
Neurobiology of addiction: treatment and public policy ramificationsCharles Dackis, Charles O'Brien
The American Journal on Addictions|December 22, 2006
Outcome predictors in cocaine dependence treatment trialsJamshid Ahmadi, Kyle Kampman, Charles Dackis
The American Journal on Addictions|January 25, 2008
Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patientsJamshid Ahmadi, Kyle Kampman, Charles Dackis, et al.
Addictive Behaviors|March 12, 2003
A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependenceKyle Kampman, Maria Dorota Majewska, Karen Tourian, et al.
The American Journal on Addictions|February 17, 2009
Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatmentJamshid Ahmadi, Kyle M Kampman, David M Oslin, et al.
Addictive Behaviors|November 30, 2010
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependenceKyle M Kampman, Charles Dackis, Helen M Pettinati, et al.
Drug and Alcohol Dependence|July 31, 2004
A pilot trial of topiramate for the treatment of cocaine dependenceKyle M Kampman, Helen Pettinati, Kevin G Lynch, et al.
Drug and Alcohol Dependence|September 1, 2015
A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependenceKyle M Kampman, Kevin G Lynch, Helen M Pettinati, et al.
Addictive Behaviors|December 15, 2007
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|December 20, 2003
Glutamatergic agents for cocaine dependenceCharles Dackis, Charles O'Brien
Nature Neuroscience|October 28, 2005
Neurobiology of addiction: treatment and public policy ramificationsCharles Dackis, Charles O'Brien
The American Journal on Addictions|December 22, 2006
Outcome predictors in cocaine dependence treatment trialsJamshid Ahmadi, Kyle Kampman, Charles Dackis
The American Journal on Addictions|January 25, 2008
Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patientsJamshid Ahmadi, Kyle Kampman, Charles Dackis, et al.
Addictive Behaviors|March 12, 2003
A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependenceKyle Kampman, Maria Dorota Majewska, Karen Tourian, et al.
The American Journal on Addictions|February 17, 2009
Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatmentJamshid Ahmadi, Kyle M Kampman, David M Oslin, et al.
Addictive Behaviors|November 30, 2010
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependenceKyle M Kampman, Charles Dackis, Helen M Pettinati, et al.
Drug and Alcohol Dependence|July 31, 2004
A pilot trial of topiramate for the treatment of cocaine dependenceKyle M Kampman, Helen Pettinati, Kevin G Lynch, et al.
Drug and Alcohol Dependence|September 1, 2015
A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependenceKyle M Kampman, Kevin G Lynch, Helen M Pettinati, et al.
Addictive Behaviors|December 15, 2007
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Pageof 2